Top

BMC Psychiatry

Published in:

Open Access 01-12-2021 | Opioids | Research article

Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control

Authors: Ingeborg Skjærvø, Thomas Clausen, Svetlana Skurtveit, Anne Bukten

Published in: BMC Psychiatry | Issue 1/2021

Abstract

Background

Reductions in crime are often reported following substance use treatment. We explore the relationship between desistance from crime, treatment type, treatment retention and positive changes in known risk factors for crime.

Methods

We used data from the NorComt-study; a longitudinal study of substance users (n = 341) enrolled in comprehensive treatment in Norway (2012–2015). At treatment initiation (T0) and 1 year later (T1), we collected self-reported data on criminal involvement, treatment, substance use, social network and self-control. We calculated adjusted odds ratios (aOR) and 95% confidence intervals (CI) with multinomial logistic regression analysis.

Results

Overall, 1 year following treatment initiation 69% reported desistance from crime, 18% reported continued crime and 12% reported no crime at all in the study period. Desistance was high for OMT patients in ongoing treatment (79% desisted) and for inpatients regardless of treatment status (79–93% desisted), while not as high among OMT patients with interrupted treatment (47% desisted). For participants that continued crime during follow-up, the average number of criminal acts per month was reduced (p < 0.001). Desistance at follow-up was associated with being older (aOR: 1.05, CI: 1.00–1.10), inpatient treatment (aOR: 3.71, CI: 1.12–12.29), being in ongoing treatment (inpatient or OMT) (aOR: 2.90, CI: 1.01–8.36), having no stimulant use in the study period (aOR: 4.86, CI: 1.72–13.70), leaving a substance using social network (aOR 2.87, CI: 1.15–7.18) and improvement in self-control score (aOR: 1.08, CI: 1.04–1.13).

Conclusions

Retention in treatment is particularly important for crime outcomes among OMT patients. Positive changes in social network and self-control are potential contributors to desistance from crime. Targeted interventions towards crime reduction are recommended for patients with stimulant use, which appears to be a persistent risk factor for crime over time.

Available only for authorised users

Marel C, Mills KL, Darke S, Ross J, Slade T, Burns L, et al. Static and dynamic predictors of criminal involvement among people with heroin dependence: findings from a 3-year longitudinal study. Drug Alcohol Depend. 2013;133(2):600–6. https://doi.org/10.1016/j.drugalcdep.2013.08.003.CrossRefPubMed

Teesson M, Ross J, Darke S, Lynskey M, Ali R, Ritter A, et al. One year outcomes for heroin dependence: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Depend. 2006;83(2):174–80. https://doi.org/10.1016/j.drugalcdep.2005.11.009.CrossRefPubMed

Best D, Hernando R, Gossop M, Sidwell C, Strang J. Getting by with a little help from your friends: the impact of peer networks on criminality in a cohort of treatment-seeking drug users. Addict Behav. 2003;28(3):597–603. https://doi.org/10.1016/S0306-4603(01)00254-4.CrossRefPubMed

Stewart D, Gossop M, Marsden J, Rolfe A. Drug misuse and acquisitive crime among clients recruited to the National Treatment Outcome Research Study (NTORS). Crim Behav Ment Health. 2000;10(1):10–20. https://doi.org/10.1002/cbm.339.CrossRef

Skjærvø I, Skurtveit S, Clausen T, Bukten A. substance use pattern, self-control and social network are associated with crime in a substance-using population. Drug Alcohol Rev. 2017;36(2):245–52. https://doi.org/10.1111/dar.12406.CrossRefPubMed

Gossop M, Marsden J, Stewart D, Rolfe A. Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug Alcohol Depend. 2000;60(3):275–86. https://doi.org/10.1016/S0376-8716(00)00109-5.CrossRefPubMed

Gossop M, Marsden J, Stewart D, Rolfe A. Reductions in acquisitive crime and drug use after treatment of addiction problems: 1-year follow-up outcomes. Drug Alcohol Depend. 2000;58(1–2):165–72. https://doi.org/10.1016/S0376-8716(99)00077-0.CrossRefPubMed

Gryczynski J, Kinlock TW, Kelly SM, O’Grady KE, Gordon MS, Schwartz RP. Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime. Subst Abus. 2012;33(1):30–9. https://doi.org/10.1080/08897077.2011.616816.CrossRefPubMed

Gossop M, Marsden J, Stewart D, Rolfe A. Treatment retention and 1 year outcomes for residential programmes in England. Drug Alcohol Depend. 1999;57(2):89–98. https://doi.org/10.1016/S0376-8716(99)00086-1.CrossRefPubMed

10.

Best D, Irving J, Albertson K. Recovery and desistance: what the emerging recovery movement in the alcohol and drug area can learn from models of desistance from offending. Addict Res Theory. 2017;25(1):1–10. https://doi.org/10.1080/16066359.2016.1185661.CrossRef

11.

Colman C, Vander LF. "recovery came first": desistance versus recovery in the criminal careers of drug-using offenders. ScientificWorldJournal. 2012;2012:657671–9. https://doi.org/10.1100/2012/657671.CrossRefPubMedPubMedCentral

12.

Bukten A, Skurtveit S, Gossop M, Waal H, Stangeland P, Havnes I, et al. Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study. Addiction. 2012;107(2):393–9. https://doi.org/10.1111/j.1360-0443.2011.03637.x.CrossRefPubMed

13.

Timko C, Nash A, Owens MD, Taylor E, Finlay AK. Systematic review of criminal and legal involvement after substance use and mental health treatment among veterans: building toward needed research. Subst Abus Res Treat. 2020;14:1178221819901281.

14.

Oliver P, Keen J, Rowse G, Ewins E, Griffiths L, Mathers N. The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service. Addiction. 2010;105(4):732–9. https://doi.org/10.1111/j.1360-0443.2009.02856.x.CrossRefPubMed

15.

Gottfredson DC, Kearley BW, Bushway SD. Substance use, drug treatment, and crime: an examination of intra-individual variation in a drug court population. J Drug Issues. 2008;38(2):601–30. https://doi.org/10.1177/002204260803800211.CrossRef

16.

McIntosh J, Bloor M, Robertson M. The effect of drug treatment upon the commission of acquisitive crime. J Subst Abus. 2007;12(5):375–84. https://doi.org/10.1080/14659890701495102.CrossRef

17.

Brunelle N, Bertrand K, Landry M, Flores-Aranda J, Patenaude C, Brochu S. Recovery from substance use: drug-dependent people’s experiences with sources that motivate them to change. Drugs Educ Prev Policy. 2015;22(3):301–7.CrossRef

18.

Stevens E, Jason LA, Ram D, Light J. Investigating social support and network relationships in substance use disorder recovery. Subst Abus. 2015;36(4):396–9. https://doi.org/10.1080/08897077.2014.965870.CrossRefPubMed

19.

Dobkin PL, Civita MD, Paraherakis A, Gill K. The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers. Addiction. 2002;97(3):347–56. https://doi.org/10.1046/j.1360-0443.2002.00083.x.CrossRefPubMed

20.

Cid J, Martí J. Imprisonment, social support, and desistance: a theoretical approach to pathways of desistance and persistence for imprisoned men. Int J Offender Ther Comp Criminol. 2017;61(13):1433–54. https://doi.org/10.1177/0306624X15623988.CrossRefPubMed

21.

Laub JH, Sampson RJ. Understanding desistance from crime. Crime Justice. 2001;28:1–69. https://doi.org/10.1086/652208.CrossRef

22.

Mills A, Codd H. Prisoners' families and offender management: mobilizing social capital. Probat J. 2008;55(1):9–24. https://doi.org/10.1177/0264550507085675.CrossRef

23.

Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, et al. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol Clin Exp Res. 2001;25(11):1634–47. https://doi.org/10.1111/j.1530-0277.2001.tb02170.x.CrossRefPubMed

24.

Gottfredson MR, Hirschi T. A general theory of crime. Stanford: Stanford University press; 1990.

25.

Vazsonyi AT, Mikuška J, Kelley EL. It's time: a meta-analysis on the self-control-deviance link. J Crim Just. 2017;48:48–63. https://doi.org/10.1016/j.jcrimjus.2016.10.001.CrossRef

26.

Burt CH. Self-control and crime: beyond Gottfredson & Hirschi's theory. Ann Rev Criminol. 2020;3(1):43–73. https://doi.org/10.1146/annurev-criminol-011419-041344.CrossRef

27.

Kalivas P, Volkow N, Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron. 2005;45(5):647–50. https://doi.org/10.1016/j.neuron.2005.02.005.CrossRefPubMed

28.

Simons JS, Dvorak RD, Batien BD, Wray TB. Event-level associations between affect, alcohol intoxication, and acute dependence symptoms: effects of urgency, self-control, and drinking experience. Addict Behav. 2010;35(12):1045–53. https://doi.org/10.1016/j.addbeh.2010.07.001.CrossRefPubMedPubMedCentral

29.

Masse LC, Tremblay RE. Behavior of boys in kindergarten and the onset of substance use during adolescence. Arch Gen Psychiatry. 1997;54(1):62–8. https://doi.org/10.1001/archpsyc.1997.01830130068014.CrossRefPubMed

30.

Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32(4):777–810. https://doi.org/10.1016/j.neubiorev.2007.11.003.CrossRefPubMed

31.

De Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol. 2009;14(1):22–31. https://doi.org/10.1111/j.1369-1600.2008.00129.x.CrossRefPubMed

32.

Baler RD, Volkow ND. Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med. 2006;12(12):559–66. https://doi.org/10.1016/j.molmed.2006.10.005.CrossRefPubMed

33.

Muraven M. Building self-control strength: practicing self-control leads to improved self-control performance. J Exp Soc Psychol. 2010;46(2):465–8. https://doi.org/10.1016/j.jesp.2009.12.011.CrossRefPubMedPubMedCentral

34.

Prioriteringsveileder Tverrfaglig spesialisert rusbehandling (TSB): Helsedirektoratet; 2012 [Available from: www.helsedirektoratet.no/prioritering.

35.

EMCDDA. Country Drug Report Norway: EMCDDA; 2017 [Available from: http://www.emcdda.europa.eu/system/files/publications/4510/TD0116916ENN.pdf_en.

36.

Hansten ML, Downey L, Rosengren DB, Donovan DM. Relationship between follow-up rates and treatment outcomes in substance abuse research: more is better but when is" enough" enough? Addiction. 2000;95(9):1403–16. https://doi.org/10.1046/j.1360-0443.2000.959140310.x.CrossRefPubMed

37.

Helsedirektoratet. Veileder for registrering i tverrfaglig spesialisert behandling for rusmiddelmisbruk (TSB): Rapportering til Norsk pasientregister 2012 [Available from: www.helsedirektoratet.no/retningslinjer/veileder-for-registrering-i-tverrfaglig-spesialisert-behandling-for-rusmiddelmisbruk-tsb.

38.

Lauritzen G, Ravndal E. Introduction of the EuropASI in Norway: clinical and research experiences from a cost-effectiveness study. J Subst Abus. 2004;9(3–4):141–6.

39.

Stevens A, Berto D, Frick U, Kerschl V, McSweeney T, Schaaf S, et al. The victimization of dependent drug users findings from a European study, UK. Eur J Criminol. 2007;4(4):385–408. https://doi.org/10.1177/1477370807080719.CrossRef

40.

Morean ME, DeMartini KS, Leeman RF, Pearlson GD, Anticevic A, Krishnan-Sarin S, et al. Psychometrically improved, abbreviated versions of three classic measures of impulsivity and self-control. Psychol Assess. 2014;26(3):1003–20. https://doi.org/10.1037/pas0000003.CrossRefPubMedPubMedCentral

41.

Maloney PW, Grawitch MJ, Barber LK. The multi-factor structure of the brief self-control scale: discriminant validity of restraint and impulsivity. J Res Pers. 2012;46(1):111–5. https://doi.org/10.1016/j.jrp.2011.10.001.CrossRef

42.

Tangney JP, Baumeister RF, Boone AL. High self-control predicts good adjustment, less pathology, better grades, and interpersonal success. J Pers. 2004;72(2):271–324. https://doi.org/10.1111/j.0022-3506.2004.00263.x.CrossRefPubMed

43.

Konttinen H, Haukkala A, Sarlio-Lähteenkorva S, Silventoinen K, Jousilahti P. Eating styles, self-control and obesity indicators. The moderating role of obesity status and dieting history on restrained eating. Appetite. 2009;53(1):131–4. https://doi.org/10.1016/j.appet.2009.05.001.CrossRefPubMed

44.

Swing EL, Gentile DA, Anderson CA, Walsh DA. Television and video game exposure and the development of attention problems. Pediatrics. 2010;126(2):214–21. https://doi.org/10.1542/peds.2009-1508.CrossRefPubMed

45.

Sun H-M, Li X-Y, Chow EP, Li T, Xian Y, Lu Y-H, et al. Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis. BMJ Open. 2015;5(1):e005997. https://doi.org/10.1136/bmjopen-2014-005997.CrossRefPubMedPubMedCentral

46.

Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93(4):515–32. https://doi.org/10.1046/j.1360-0443.1998.9345157.x.CrossRefPubMed

47.

Garnick DW, Horgan CM, Acevedo A, Lee MT, Panas L, Ritter GA, et al. Criminal justice outcomes after engagement in outpatient substance abuse treatment. J Subst Abus Treat. 2014;46(3):295–305. https://doi.org/10.1016/j.jsat.2013.10.005.CrossRef

48.

Robertson IE, Nesvåg SM. Into the unknown: treatment as a social arena for drug users’ transition into a non-using life. Nordic Stud Alcohol Drugs. 2019;36(3):248–66. https://doi.org/10.1177/1455072518796898.CrossRef

49.

Årstad J, Nesvåg SM, Njå A-LM, Biong SN. How enough becomes enough: processes of change prior to treatment for substance use disorder. J Subst Abus. 2018;23(4):429–35. https://doi.org/10.1080/14659891.2018.1436608.CrossRef

50.

Best D, Day E, Campbell A, Flynn PM, Simpson DD. Relationship between drug treatment engagement and criminal thinking style among drug-using offenders. Eur Addict Res. 2009;15(2):71–7. https://doi.org/10.1159/000189785.CrossRefPubMed

51.

Stavseth MR, Røislien J, Bukten A, Clausen T. Factors associated with ongoing criminal engagement while in opioid maintenance treatment. J Subst Abus Treat. 2017;77:52–6. https://doi.org/10.1016/j.jsat.2017.03.010.CrossRef

52.

Boles SM, Miotto K. Substance abuse and violence: a review of the literature. Aggress Violent Behav. 2003;8(2):155–74. https://doi.org/10.1016/S1359-1789(01)00057-X.CrossRef

53.

Leland DS, Paulus MP. Increased risk-taking decision-making but not altered response to punishment in stimulant-using young adults. Drug Alcohol Depend. 2005;78(1):83–90. https://doi.org/10.1016/j.drugalcdep.2004.10.001.CrossRefPubMed

54.

Carrol EN, Zuckerman M. Psychopathology and sensation seeking in “downers,”“speeders,” and “trippers”: A study of the relationship between personality and drug choice. Int J Addict. 1977;12(4):591–601. https://doi.org/10.3109/10826087709027247.CrossRef

55.

Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia. 2001;39(4):376–89. https://doi.org/10.1016/S0028-3932(00)00136-6.CrossRefPubMed

56.

Rogers RD, Everitt B, Baldacchino A, Blackshaw A, Swainson R, Wynne K, et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology. 1999;20(4):322–39. https://doi.org/10.1016/S0893-133X(98)00091-8.CrossRefPubMed

57.

Strickland JC, Beckmann JS, Rush CR, Stoops WW. A pilot study of loss aversion for drug and non-drug commodities in cocaine users. Drug Alcohol Depend. 2017;180:223–6. https://doi.org/10.1016/j.drugalcdep.2017.08.020.CrossRefPubMedPubMedCentral

58.

Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;386(10010):2287–323.CrossRef

59.

Merrin GJ, Davis JP, Berry D, D’Amico EJ, Dumas TM. The longitudinal associations between substance use, crime, and social risk among emerging adults: a longitudinal within and between-person latent variables analysis. Drug Alcohol Depend. 2016;165:71–8. https://doi.org/10.1016/j.drugalcdep.2016.05.009.CrossRefPubMed

60.

Best D, Gow J, Taylor A, Knox A, White W. Recovery from heroin or alcohol dependence: a qualitative account of the recovery experience in Glasgow. J Drug Issues. 2011;41(3):359–77. https://doi.org/10.1177/002204261104100303.CrossRef

61.

Malouf ET, Schaefer KE, Witt EA, Moore KE, Stuewig J, Tangney JP. The brief self-control scale predicts jail inmates’ recidivism, substance dependence, and post-release adjustment. Personal Soc Psychol Bull. 2014;40(3):334–47. https://doi.org/10.1177/0146167213511666.CrossRef

62.

Packer G, Best D, Day E, Wood K. Criminal thinking and self-control among drug users in court mandated treatment. Criminol Crim Just. 2009;9(1):93–110. https://doi.org/10.1177/1748895808099182.CrossRef

63.

Ronan G, Gerhart JI, Dollard K, Maurelli KA. An analysis of survival time to re-arrest in treated and non-treated jailers. J Forensic Psychiatry Psychol. 2010;21(1):102–12. https://doi.org/10.1080/14789940903215288.CrossRef

64.

Verdejo-García A, Lorenzetti V, Manning V, Piercy H, Bruno R, Hester R, et al. A Roadmap for Integrating neuroscience into addiction treatment: a consensus of the neuroscience interest group of the international society of addiction medicine. Front Psychiatry. 2019;10:877.CrossRef

65.

Hendershot CS, Wardell JD, Vandervoort J, McPhee MD, Keough MT, Quilty LC. Randomized trial of working memory training as an adjunct to inpatient substance use disorder treatment. Psychol Addict Behav. 2018;32(8):861–72. https://doi.org/10.1037/adb0000415.CrossRefPubMed

66.

Betts KS, Chan G, McIlwraith F, Dietze P, Whittaker E, Burns L, et al. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies. Addiction. 2016;111(7):1214–23. https://doi.org/10.1111/add.13339.CrossRefPubMed

67.

Chaiken JM, Chaiken MR, Peterson JE. Varieties of criminal behavior. 1982.

68.

Thornberry TP, Krohn MD. The self-report method for measuring delinquency and crime. Crim Justice. 2000;4(1):33–83.

69.

Johnson BD, Taylor A, Golub A. Research note: how accurate are Arrestees' self-reports of their criminal justice histories? Justice Res Policy. 2005;7(1):81–101. https://doi.org/10.3818/JRP.7.1.2005.81.CrossRef

70.

Lauritzen GO, Ravndal E, Larsson JL. Gjennom 10 år. En oppfølgingsundersøkelse av narkotikabrukere i behandling 2012.

Title: Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control
Authors: Ingeborg Skjærvø
Thomas Clausen
Svetlana Skurtveit
Anne Bukten
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Opioids
Opioids
Published in: BMC Psychiatry / Issue 1/2021
Electronic ISSN: 1471-244X
DOI: https://doi.org/10.1186/s12888-021-03518-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Physical multimorbidity and lifetime suicidal ideation and plans among rural older adults: the mediating role of psychological distress

Professional perspectives on providing recovery-oriented services in Taiwan: a qualitative study

Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use

Prevalence and influencing factors of chronic post-traumatic stress disorder in patients with myocardial infarction, transient ischemic attack (TIA) and stroke – an exploratory, descriptive study

Atypical Charles Bonnet syndrome secondary to frontal meningioma: a case report

Resilience, coping, and distress among healthcare service personnel during the COVID-19 pandemic